Biocure Technology

Biocure Technology Enterprise Value

The Enterprise Value (EV) of Biocure Technology (CURE.X.CN) as of Oct 16, 2026 is 571,600.00 CAD. In the previous year, Enterprise Value (EV) was 577,700.00 CAD — a change of -1.06% (lower).

Enterprise Value

571,600.00CAD

YoY

-1.06%

Last updated:

Enterprise Value (EV) of Biocure Technology is 2024 571,600.00 CAD. Enterprise Value (EV) of Biocure Technology was 2023 577,700.00 CAD. It decreases by -1.06% lower compared to the previous year.

The Biocure Technology Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2017
540,000.00 CAD
Jan 1, 2018
540,000.00 CAD
Jan 1, 2019
540,000.00 CAD
Jan 1, 2020
4.48 M CAD
Jan 1, 2021
4.17 M CAD
Jan 1, 2022
583,500.00 CAD
Jan 1, 2023
577,700.00 CAD
Jan 1, 2024
571,600.00 CAD
The Biocure Technology Enterprise Value history
YEAREnterprise ValueYoY
571,600.00CAD-1.06%
577,700.00CAD-0.99%
583,500.00CAD-86.01%
4.17 MCAD-7.00%
4.48 MCAD+730.44%
540,000.00CAD0.00%
540,000.00CAD0.00%
540,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biocure Technology Stock analysis

What does Biocure Technology do? Biocure Technology Inc is a biotechnology company based in Vancouver, Canada, operating within the health care sector. The company went public on March 27, 2008, with the ticker CURE.X.CN and ISIN CA09075T2065. Its primary focus involves the development and commercialization of biosimilar products. Biocure Technology Inc is engaged in the development of biopharmaceutical technologies, including recombinant and ranibizumab-related applications. The company's product portfolio includes Interferon Beta, Ranibizumab, and PEG-Filgrastim. While the source description mentions CAR T-cell therapy targeting Chronic lymphocytic leukemia and solid tumor cancers, this information is not confirmed by the provided facts and is excluded. Similarly, the company's involvement in biosimilar technologies for cancer treatment is noted but not elaborated with specific details. Biocure Technology Inc's website is https://biocuretech.com/, where further information can be found. The company operates as a public entity with a presence in the biotechnology industry, focusing on innovative therapeutic solutions. No additional details regarding founding year, key personnel, acquisitions, or specific financial figures are provided in the available information. Biocure Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocure Technology stock

Enterprise Value (EV) of Biocure Technology is 571,600.00 CAD in 2024.

Enterprise Value (EV) of Biocure Technology changed from 577,700.00 CAD to 571,600.00 CAD, representing a -1.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Biocure Technology since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s CAD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' CAD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Biocure Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Biocure Technology

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Biocure Technology